scispace - formally typeset
Search or ask a question
Author

Michael Farrell

Bio: Michael Farrell is an academic researcher from National Drug and Alcohol Research Centre. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 103, co-authored 753 publications receiving 35615 citations. Previous affiliations of Michael Farrell include Universidade Federal de Pelotas & Wellington Management Company.


Papers
More filters
Journal ArticleDOI
TL;DR: The ASSIST items are reliable and feasible to use as part of an international screening test and can serve as the basis for more extensive validation research.
Abstract: WHO ASSIST Working Group member: Robert Ali for Drug and Alcohol Addiction Services Council, Adelaide, Australia

1,385 citations

Journal ArticleDOI
TL;DR: The findings demonstrated that the ASSIST is a valid screening test for identifying psychoactive substance use in individuals who use a number of substances and have varying degrees of substance use.
Abstract: Aim The concurrent, construct and discriminative validity of the World Health Organization's Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) were examined in a multi-site international study. Participants One thousand and 47 participants, recruited from drug treatment (n = 350) and primary health care (PHC) settings (n = 697), were administered a battery of instruments. Measurements Measures included the ASSIST; the Addiction Severity Index-Lite (ASI-Lite); the Severity of Dependence Scale (SDS); the MINI International Neuropsychiatric Interview (MINI-Plus); the Rating of Injection Site Condition (RISC); the Drug Abuse Screening Test (DAST); the Alcohol Use Disorders Identification Test (AUDIT); the Revised Fagerstrom Tolerance Questionnaire (RTQ); and the Maudsley Addiction Profile (MAP). Findings Concurrent validity was demonstrated by significant correlations between ASSIST scores and scores from the ASI-Lite (r = 0.76–0.88), SDS (r = 0.59), AUDIT (r = 0.82) and RTQ (r = 0.78); and significantly greater ASSIST scores for those with MINI-Plus diagnoses of abuse or dependence (P < 0.001). Construct validity was established by significant correlations between ASSIST scores and measures of risk factors for the development of drug and alcohol problems (r = 0.48–0.76). Discriminative validity was established by the capacity of the ASSIST to discriminate between substance use, abuse and dependence. Receiver operating characteristic (ROC) analysis was used to establish cut-off scores with suitable specificities (50–96%) and sensitivities (54–97%) for most substances. Conclusions The findings demonstrated that the ASSIST is a valid screening test for identifying psychoactive substance use in individuals who use a number of substances and have varying degrees of substance use.

905 citations

Journal ArticleDOI
TL;DR: In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability-adjusted life years, with illicit drugs costing further tens of millions.
Abstract: Amy Peacock, Janni Leung, Sarah Larney, Samantha Colledge, Matthew Hickman, Jurgen Rehm, Gary A. Giovino, Robert West, Wayne Hall, Paul Griffiths, Robert Ali, Linda Gowing, John Marsden, Alize J. Ferrari, Jason Grebely, Michael Farrell and Louisa Degenhardt

623 citations

Journal ArticleDOI
TL;DR: For example, this paper used a representative general population sample of 699 adolescents and their families to examine the effects of parenting practices, particularly support and control, on the development of adolescent drinking, delinquency, and other problem behaviors.
Abstract: This study uses a representative general population sample of 699 adolescents and their families to examine the effects of parenting practices, particularly support and control, on the development of adolescent drinking, delinquency, and other problem behaviors. Black families were oversampled (n = 211) to permit meaningful analyses. The findings confirm that parental support and monitoring are important predictors of adolescent outcomes even after taking into account critical demographic/family factors, including socioeconomic indicators, age, gender, and race of the adolescent, family structure, and family history of alcohol abuse. In addition, peer orientation remains a significant predictor of drinking behavior and deviance and interacts with aspects of parenting. Methodological issues associated with sampling, family respondent, and measurement of support and control are critiqued as they pertain to parental socialization and adolescent outcome research. (Abstract Adapted from Source: Journal of Marriage and the Family, 1992. Copyright © 1992 by the National Council on Family Relations) Parental Control Parental Support Parenting Practices Juvenile Behavior Juvenile Delinquency Juvenile Offender Juvenile Problem Behavior Juvenile Substance Use Family Relations Parent Child Relations Family Risk Factors Delinquency Causes Delinquency Predictors Delinquency Risk Factors Behavior Causes Behavior Predictors Behavior Risk Factors Substance Use Causes Substance Use Risk Factors Substance Use Predictors Alcohol Use Causes 07-03

608 citations

Journal ArticleDOI
TL;DR: There is an increased risk of drug-related death during the first 2 weeks after release from prison and that the risk remains elevated up to at least the fourth week, a meta-analysis confirms.
Abstract: Aims The transition from prison back into the community is particularly hazardous for drug-using offenders whose tolerance for heroin has been reduced by imprisonment. Studies have indicated an increased risk of drug-related death soon after release from prison, particularly in the first 2 weeks. For precise, up-to-date understanding of these risks, a meta-analysis was conducted on the risk of drug-related death in weeks 1 + 2 and 3 + 4 compared with later 2-week periods in the first 12 weeks after release from prison.Methods English-language studies were identified that followed up adult prisoners for mortality from time of index release for at least 12 weeks. Six studies from six prison systems met the inclusion criteria and relevant data were extracted independently. Results These studies contributed a total of 69 093 person-years and 1033 deaths in the first 12 weeks after release, of which 612 were drug-related. A three- to eightfold increased risk of drug-related death was found when comparing weeks 1 + 2 with weeks 3-12, with notable heterogeneity between countries: United Kingdom, 7.5 (95% CI: 5.7-9.9); Australia, 4.0 (95% CI: 3.4-4.8); Washing- ton State, USA, 8.4 (95% CI: 5.0-14.2) and New Mexico State, USA, 3.1 (95% CI: 1.3-7.1). Comparing weeks 3 + 4 with weeks 5-12, the pooled relative risk was: 1.7 (95% CI: 1.3-2.2). Conclusions These findings confirm that there is an increased risk of drug-related death during the first 2 weeks after release from prison and that the risk remains elevated up to at least the fourth week.

545 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: Because of the increased complexity of analysis and interpretation of clinical genetic testing described in this report, the ACMG strongly recommends thatclinical molecular genetic testing should be performed in a Clinical Laboratory Improvement Amendments–approved laboratory, with results interpreted by a board-certified clinical molecular geneticist or molecular genetic pathologist or the equivalent.

17,834 citations

Book
10 Feb 2011
TL;DR: The perfect complement to Nursing Research: Generating and Assessing Evidence for Nursing Practice, Ninth Edition, this knowledge builder helps you develop and reinforce basic skills essential to nursing research.
Abstract: The perfect complement to Nursing Research: Generating and Assessing Evidence for Nursing Practice, Ninth Edition, this knowledge builder helps you develop and reinforce basic skills essential to nursing research.

3,409 citations

Journal ArticleDOI
TL;DR: Effect size estimates suggest that mindfulness-based therapy was moderately effective for improving anxiety and mood symptoms from pre- to posttreatment in the overall sample, and this intervention is a promising intervention for treating anxiety and Mood problems in clinical populations.
Abstract: Objective:Although mindfulness-based therapy has become a popular treatment, little is known about its efficacy. Therefore, our objective was to conduct an effect size analysis of this popular intervention for anxiety and mood symptoms in clinical samples.Method:We conducted a literature search using PubMed, PsycINFO, the Cochrane Library, and manual searches. Our meta-analysis was based on 39 studies totaling 1,140 participants receiving mindfulness-based therapy for a range of conditions, including cancer, generalized anxiety disorder, depression, and other psychiatric or medical conditions. Results:Effect size estimates suggest that mindfulness-based therapy was moderately effective for improving anxiety (Hedges’sg!0.63) and mood symptoms (Hedges’sg!0.59) from pre- to posttreatment in the overall sample. In patients with anxiety and mood disorders, this intervention was associated with effect sizes (Hedges’sg) of 0.97 and 0.95 for improving anxiety and mood symptoms, respectively. These effect sizes were robust, were unrelated to publication year or number of treatment sessions, and were maintained over follow-up.Conclusions:These results suggest that mindfulnessbased therapy is a promising intervention for treating anxiety and mood problems in clinical populations.

3,115 citations